Found 11 matching trials
Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia PHASE1 The purpose of this study is to evaluate the safety, pharmacokinetic and ph...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Determine the Bioavailability of Lanadelumab (SHP643) Administered Subcutaneously With the Prefilled Syringe and the Autoinjector in Healthy Adult Volunteer Participants. PHASE1 The purpose of this study is to evaluate bioavailability of lanadelumab (SH...
Show More Location
Clinical Pharmacology of Miami, LLC
Learn More & Join Trial
Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult Subjects PHASE1 The purpose of this study is to evaluate the pharmacokinetics (PK), safety ...
Show More Location
WCCT Global, Inc.
Learn More & Join Trial
Efficacy and Safety of Lanadelumab (SHP643) in Japanese Participants With Hereditary Angioedema (HAE) PHASE3 The purpose of this phase 3, open-label, multi-center study is to evaluate ...
Show More Location
Toyohashi Municipal Hospital
Learn More & Join Trial
A Study of Lanadelumab (SHP643) in Chinese Participants With Hereditary Angioedema (HAE) PHASE3 The main aim of this study is to evaluate the safety of lanadelumab in Chin...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE PHASE3 This study is an open-label, long term safety and efficacy study to evaluat...
Show More Location
Clinical Research Center of Alabama
Learn More & Join Trial
A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) PHASE3 The main aim of this study is to check if repeated subcutaneous (SC) inject...
Show More Location
Clinical Research Center of Alabama
Learn More & Join Trial
Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults N/A The expanded access program allows people to gain access to an unlicensed t...
Show More Status
No Longer Available
Location
Medical Research of Arizona
Learn More & Join Trial
A Study of Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in Children PHASE3 The main aims of this study are to learn how lanadelumab moves through a ch...
Show More Location
AIRE Medical of Los Angeles
Learn More & Join Trial
A Survey of Lanadelumab in Participants With Hereditary Angioedema N/A This study is a survey in Japan of Lanadelumab used to treat people with he...
Show More Status
Active Not Recruiting
Location
Takeda selected site
Learn More & Join Trial